Christina M. Lill, MD, MS

Group leader

Positions

Current:

(1) Research group leader, Genetic and Molecular Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Germany (since 2018)

(2) Lecturer (part-time), School of Public Health, Imperial College London (ICL), UK (since 2018)

(3) Resident in Medical Genetics, Institute of Human Genetics, University of Lübeck, Germany (since 2016)

Past:

Resident in Medical Genetics, Charité University Medicine, Berlin, Germany (2008-2009), postdoctoral researcher, Johannes Gutenberg University, Mainz, Germany (2010-2011), postdoctoral researcher, Max Planck Institute for Molecular Genetics, Berlin, Germany (2012-2014), postdoctoral researcher, Institute of Neurogenetics, University of Lübeck, Germany (2015-2016), Research group leader, Institute of Neurogenetics, University of Lübeck, Germany (2016-2018)

 

Education/training:

Institution and location Degree Year Field of study
Ludwig Maximilian University Munich M.D. 2005 Medicine
Massachusetts Institute for Neurodegenerative Disease, Harvard Medical School, Boston Predoctoral fellowship 2006-07 Neuroscience, genetics
Charité University Medicine, Berlin Residency 2008-09 Medical genetics (training in neurology)
Westfälische Wilhelms University, Münster Dissertation (Dr. med.) 2011 Neurogenetics
Johannes Gutenberg University, Mainz M.Sc. 2015 Epidemiology
University of Lübeck, Lübeck, Germany Residency 2016-current Medical genetics (genetic counseling)

 

Major current funding (projects as (co-)PI only):

DFG (FOR2488/1, GZ LI 2654/2-1), budget: €277,760, funding period: 2016-2020 (PI)

ERC/H2020 (#732592), budget: €1,112,545, funding period: 2017-2022 (local co-PI)

MJFF, budget: ~€650,000, funding period: starting in autumn 2019-2022 (PI)

 

Selected publications (from >80 papers; >3,600 citations; h-index: 26, source: Scopus database, June 2019):

(1) Lill CM, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: The PDGene database. PLoS Genet, 2012; 8(3): e1002548; IF = 8.5

(2) Lill CM, et al. MANBA, CXCR5, SOX8, RPS6KB1, and ZBTB46 are genetic risk loci for multiple sclerosis. Brain, 2013;136(Pt 6):1778-82; IF = 10.2

(3) Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet, 2014 46(9):989-93; IF = 29.4

(4) Lill CM, et al. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimers Dement, 2015;11(12):1407-1416;IF = 11.6

(5) Wohlers I, Bertram L, Lill CM. Evidence for a potential role of miR-1908-5p and miR-3614-5p in autoimmune disease risk using integrative bioinformatics. J Autoimmun. 2018;94:83-89. .; IF = 7.5

(6) Paul KC*, Schulz J*, Bronstein JM, Lill CM*, Ritz BR*. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease. JAMA Neurol. 2018;75(3):360-366; IF = 12.3

(7) Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rücker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM. Meta-analyses identify differentially expressed microRNAs in Parkinson’s disease, Ann Neurol, 2019;85(6):835-851.; IF = 10.2

*shared first or last authors

 

Awards & memberships

Awards

2016     “Young Leaders in Science” Program of the Schering Foundation
2015     Renate-Maaß Award for Brain Research
2015     Travel award of the GlaxoSmithKline foundation
2009     Travel award of the Felgenhauer foundation
2006 – 2007     MD thesis research scholarship (Promotionsstipendium) of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst)
2000 – 2005     Scholarship of the e-fellows.net GmbH & Co KG
1999 – 2005     Scholarship of the German National Merit Foundation (Studienstiftung des deutschen Volkes)

Current memberships

Co-leader of the Epidemiology Working Group of the International Parkinson and Movement Disorder Society (MDS)
Co-leader of the Epidemiology and Statistics Core at the Genetic Epidemiology of Parkinson’s Disease Consortium (GEO-PD)
Editorial boards of Gene, Mol Cell Probes (Elsevier)
Extended Steering Committee of the Berlin Aging Study II (BASE II)
Genetic Epidemiology of Parkinson’s Disease Consortium (GEO-PD)
Harvard European Alumni Training NETwork for the study of neurodegenerative disorders (HEAT-NET)
International Multiple Sclerosis Genetics Consortium (IMSGC)